Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P02794 (
ferritin
)
17,525
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Familial combined hyperlipidemia (FCH) and
familial hypertriglyceridemia
(FHTG) share pathogenic mechanisms and a high interaction with components of the metabolic syndrome. The metabolic syndrome associates increased serum
ferritin
concentration and high cardiovascular risk. The objective was to describe the frequency of iron overload and the relationship between serum
ferritin
and the phenotype in patients with FCH and FHTG. The study was composed of 211 consecutive unrelated patients aged at least 18 years with primary hypertriglyceridemia, 149 with FCH, and 62 with FHTG. The prevalence of the metabolic syndrome and hyperferritinemia was very high in both hypertriglyceridemic groups (51.7% and 20.1% in FCH and 62.9% and 16.1% in FHTG, respectively), without significant statistical differences between them. Serum
ferritin
concentration did not show any significant association with the number of metabolic syndrome criteria. Subjects in the highest tertile of
ferritin
concentration (
ferritin
>200 mug/L) presented higher concentrations of triglycerides and liver enzymes than subjects in the first tertile of
ferritin
concentration (
ferritin
<90 mug/L). The highest positive correlation coefficient for triglycerides was found with
ferritin
in FCH and in FHTG subjects (R = 0.317 [P < .001] when combined). Ferritin was also the covariate that showed the highest independent association with triglycerides in FCH and FHTG. In contrast,
ferritin
was not associated with carotid intima-media thickness. In summary, serum
ferritin
is commonly increased in FCH and in FHTG, it is not related with the presence of metabolic syndrome, and it is highly correlated with liver enzymes.
...
PMID:Serum ferritin is a major determinant of lipid phenotype in familial combined hyperlipidemia and familial hypertriglyceridemia. 1991 43
Iron deposits are associated with lipid phenotype in familial hypertriglyceridemias, mainly familial combined hyperlipidemia (FCH) and
familial hypertriglyceridemia
(FHTG). In turn, diet plays an important role in hypertriglyceridemias although it is not known if dietary patterns are associated with iron concentration in these disorders. The objective was to determine the relationship between diet and iron deposits, measured through serum
ferritin
concentration, in patients with FCH and FHTG. The study was composed of 140 patients, 107 with FCH and 33 with FHTG. Subjects completed a validated 137-item food frequency questionnaire. Dividing subjects by
ferritin
tertiles adjusted by sex, there were no significant differences in dietary patterns except in dairy products consumption which was lower in the highest
ferritin
tertile. Subjects were also divided by triglycerides tertiles adjusted by sex. Those subjects in the highest tertile had lower HDL cholesterol and higher
ferritin
concentrations. Regarding to dietary parameters, there were significant differences in marine omega three fatty acids and vegetables presenting higher and lower consumption, respectively, those patients in the highest tertile of triglycerides. Moreover, there was not a significant correlation between dietary iron intake and any parameter, both biochemical and dietary, including
ferritin
concentrations. In conclusion, in patients with primary hypertriglyceridemia, triglycerides are associated with
ferritin
concentrations but dietary patterns are not related to iron deposits. Our results highly support the concept that the genetic mechanisms driven to hypertriglyceridemia also favor iron overload.
...
PMID:Iron deposits and dietary patterns in familial combined hyperlipidemia and familial hypertriglyceridemia. 2064 39